microdose semaglutide side effects Microdosing for GLP-1s for Menopause-Related Weight Gain Ozempic 'microdosing' is becoming popular.

Abstract LB-495066-04

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Gallbladder or Biliary Disease

As research on GLP-1RAs expands in the cognitive and mental health area, we may be able to distinguish between direct effects on cognitive and mental health outcomes and effects that are mediated by GLP-1RAs actions on cardiovascular and metabolic outcomes

FDA Disclaimer These statements have not been evaluated by the Food and Drug Administration

We assessed whether providers clearly listed pricing for medications, consultations, lab work, and follow-up care

The number of monthly prescription fills for semaglutide increased by 442% from 2021 to 2023, according to a research letter published in JAMA Health Forum